Immunocore Holdings Plc ADR (IMCR)
25.00 x 1 36.00 x 2
Post-market by (Cboe BZX)
28.41 +0.54 (+1.94%) 04/17/25 [NASDAQ]
25.00 x 1 36.00 x 2
Post-market 28.41 unch (unch) 16:00 ET
for Thu, Apr 17th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -51,087 | -55,287 | -52,543 | -180,857 | -95,135 |
Depreciation Amortization | 4,204 | 4,090 | 5,335 | 9,642 | 11,525 |
Accounts receivable | -12,348 | -17,871 | -26,264 | -7,078 | -683 |
Accounts payable and accrued liabilities | 7,272 | 2,625 | 4,913 | 13,021 | -4,846 |
Other Working Capital | 45,129 | 5,782 | -24,165 | -23,110 | -36,983 |
Other Operating Activity | 32,891 | 63,601 | 43,515 | 56,221 | 48,345 |
Operating Cash Flow | $26,061 | $2,940 | $-49,209 | $-132,161 | $-77,777 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -350,000 | N/A | N/A | N/A | N/A |
PPE Investments | -5,129 | -5,425 | -2,197 | -1,280 | -3,080 |
Other Investing Activity | 0 | 0 | 0 | 776 | 3,680 |
Investing Cash Flow | $-355,129 | $-5,425 | $-2,197 | $-505 | $600 |
Cash Flows From Financing Activities | |||||
Debt Repayment | -50,000 | N/A | -50,000 | N/A | N/A |
Common Stock Issued | 6,800 | 34,346 | 149,211 | 312,808 | 106,946 |
Other Financing Activity | 387,081 | 0 | 46,231 | -31,420 | 41,923 |
Financing Cash Flow | $343,881 | $34,346 | $145,442 | $281,388 | $148,868 |
Exchange Rate Effect | -1,708 | 8,293 | -12,646 | 22 | -108 |
Beginning Cash Position | 442,626 | 402,472 | 321,082 | 178,373 | 94,972 |
End Cash Position | 455,731 | 442,626 | 402,472 | 327,117 | 166,555 |
Net Cash Flow | $13,105 | $40,154 | $81,390 | $148,745 | $71,583 |
Free Cash Flow | |||||
Operating Cash Flow | 26,061 | 2,940 | -49,209 | -132,161 | -77,777 |
Capital Expenditure | -5,173 | -5,425 | -2,203 | -1,386 | -3,947 |
Free Cash Flow | 20,888 | -2,485 | -51,412 | -133,547 | -81,724 |